During the past decade, Nihonbashi Sakura Clinic conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nihonbashi Sakura Clinic" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Nihonbashi Sakura Clinic" are "Atopic Dermatitis" (3 trials), "Nocturia" (2 trials), "Diabetes Mellitus, Type 2" (1 trials), "Lower Respiratory Tract Illness" (1 trials) and "Pneumococcal Disease" (1 trials). Many other conditions were trialed in "Nihonbashi Sakura Clinic" in a lesser frequency.

Most popular intervention types in "Nihonbashi Sakura Clinic" are "Drug" (9 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Baricitinib" (3 trials), "Tirzepatide" (2 trials), "13vPnC" (1 trials) and "20vPnC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nihonbashi Sakura Clinic" are 9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nihonbashi Sakura Clinic". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Nihonbashi Sakura Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nihonbashi Sakura Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".